Buy 3-MeO-PCE USA Domestic, Canada, 3-Methoxyphencyclidine
is an unique dissociative drug that belongs to the arylcyclohexylamine class that, when taken, generates effects that are both dissociative and hallucinogenic. It has the same structural characteristics as PCE.
In 2010, 3-meO-PCE started to see a rise in popularity and is now being offered on the internet grey area research chemical market as a legitimate substitute for PCP or ketamine.
There is a very limited amount of information available on the pharmacological effects, metabolic processes, and hazardous potential of 3-meO-PCE, and its use in humans has a fairly recent history. It is highly suggested that anybody who uses this drug engage in behaviors that minimize the potential for negative consequences.
Our research chemicals are, for the most part, structural or functional analogs of controlled substances. These analogs have been designed to mimic the pharmacological effects of the original drug, but they do not fall into the category of being an illegal substance and/or are not detectable in standard drug tests. Analogs of performance-enhancing pharmaceuticals and psychotropic compounds are both included in the category of research chemicals. Some of them were first created by academic or industrial researchers in an attempt to identify more effective compounds with fewer adverse effects; subsequently, they were co-opted for usage in recreational activities. Other research substances were manufactured for the very first time in underground facilities. Because the effectiveness and safety of these chemicals have not been adequately tested in animal and human studies, the use of some of these medications may result in unanticipated adverse effects.
It’s possible that the creation of designer medications may be regarded an area of drug design. The investigation of modifications to known active drugs, such as their structural analogues, stereoisomers, and derivatives, results in the production of drugs that may exhibit effects that are significantly different from those of their “parent” drug (for example, demonstrating increased potency or decreased side effects). In some cases, designer medications have the same effects as other pharmaceuticals that are already on the market, but their molecular structures are entirely different (for example, JWH-018 is not the same as THC). In spite of the fact that it is a fairly general phrase that may be used to nearly any synthetic drug, it is often used to refer to synthetic medicines that are taken for recreational purposes, and occasionally even medications that have not been developed at all (e.g. LSD, the psychedelic side effects of which were discovered unintentionally).
There are no reviews yet.